MedPath

Sildenafil Citrate

These highlights do not include all the information needed to use SILDENAFIL TABLETS safely and effectively. See full prescribing information for SILDENAFIL TABLETS. SILDENAFIL tablets, for oral use Initial U.S. Approval: 1998

Approved
Approval ID

a3752548-1472-48b6-9998-119f8a9ecb8d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 2, 2018

Manufacturers
FDA

Vensun Pharmaceuticals, Inc.

DUNS: 078310501

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sildenafil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42543-005
Application NumberANDA204883
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sildenafil
Product Specifications
Route of AdministrationORAL
Effective DateJuly 15, 2016
FDA Product Classification

INGREDIENTS (9)

SILDENAFIL CITRATEActive
Quantity: 20 mg in 1 1
Code: BW9B0ZE037
Classification: ACTIM
SILICA DIMETHYL SILYLATEInactive
Code: EU2PSP0G0W
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sildenafil Citrate - FDA Drug Approval Details